Literature DB >> 17185901

Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women.

T Yasui1, H Uemura, J Tomita, Y Miyatani, M Yamada, M Miura, M Irahara.   

Abstract

OBJECTIVE: We investigated changes in serum concentration of undercarboxylated osteocalcin (ucOC), which is a sensitive marker of vitamin K status, and association of ucOC concentration with estradiol concentration in pre-, peri- and early post-menopausal women.
METHODS: The study population consisted of 193 pre-, peri- and post-menopausal Japanese women aged 39-66 yr. Serum ucOC concentration was measured to assess vitamin K status; serum concentrations of intact osteocalcin (OC) and bone-specific alkaline phosphatase (BAP) were measured as bone formation markers; and urine concentration of N-telopeptide was measured as a bone resorption marker. Serum estradiol and estrone concentrations were measured by a highly sensitive radioimmunoassay. Bone mineral density (BMD) was measured at the lumbar spine.
RESULTS: Serum concentration of ucOC in peri-menopausal women was significantly (p=0.0005) higher than that in pre-menopausal women, while serum OC concentration in post-menopausal women for whom 1 yr had passed since menopause was significantly (p=0.0003, p=0.024, respectively) higher than the concentrations in pre-menopausal and peri-menopausal women. Serum ucOC concentration showed a significant negative correlation with estradiol concentration (r=-0.372, p<0.0001) and a significant positive correlation with serum FSH concentration (r=0.324, p<0.0001). Serum OC concentration was positively correlated with serum FSH concentration (r=0.317, p<0.001).
CONCLUSIONS: The results showed that the change in ucOC concentration during the menopausal transition is different from that in OC concentration. In addition, serum ucOC concentration is closely associated not only with FSH concentration but also estradiol concentration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185901     DOI: 10.1007/BF03349196

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  Concentrations of follicle-stimulating hormone correlate with alkaline phosphatase and a marker for vitamin K status in the perimenopause.

Authors:  J L Lukacs; N E Reame
Journal:  J Womens Health Gend Based Med       Date:  2000-09

2.  Bone metabolism during the perimenopausal transition: a prospective study.

Authors:  Vanadin Seifert-Klauss; Judith E Mueller; Peter Luppa; Reiner Probst; Jennifer Wilker; Cornelia Höss; Thomas Treumann; Christian Kastner; Kurt Ulm
Journal:  Maturitas       Date:  2002-01-30       Impact factor: 4.342

3.  Undercarboxylated osteocalcin concentration in postmenopausal women receiving hormone therapy daily and on alternate days.

Authors:  Toshiyuki Yasui; Hirokazu Uemura; Yuka Umino; Masayo Yamada; Akira Kuwahara; Toshiya Matsuzaki; Masahiko Maegawa; Hiroyuki Furumoto; Masakazu Miura; Minoru Irahara
Journal:  Menopause       Date:  2006 Mar-Apr       Impact factor: 2.953

4.  Vitamin K2 binds 17beta-hydroxysteroid dehydrogenase 4 and modulates estrogen metabolism.

Authors:  Motoyuki Otsuka; Naoya Kato; Tohru Ichimura; Shinya Abe; Yasuo Tanaka; Hiroyoshi Taniguchi; Yujin Hoshida; Masaru Moriyama; Yue Wang; Run-Xuan Shao; Dharel Narayan; Ryosuke Muroyama; Fumihiko Kanai; Takao Kawabe; Toshiaki Isobe; Masao Omata
Journal:  Life Sci       Date:  2005-04-08       Impact factor: 5.037

5.  Bone turnover markers and bone density across the menopausal transition.

Authors:  P R Ebeling; L M Atley; J R Guthrie; H G Burger; L Dennerstein; J L Hopper; J D Wark
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

6.  Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study.

Authors:  P Vergnaud; P Garnero; P J Meunier; G Bréart; K Kamihagi; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

7.  Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women.

Authors:  R D Chapurlat; P Garnero; E Sornay-Rendu; M E Arlot; B Claustrat; P D Delmas
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

8.  Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum.

Authors:  B Gomez; S Ardakani; J Ju; D Jenkins; M J Cerelli; G Y Daniloff; V T Kung
Journal:  Clin Chem       Date:  1995-11       Impact factor: 8.327

9.  Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin.

Authors:  C M Gundberg; S D Nieman; S Abrams; H Rosen
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

10.  Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study.

Authors:  P Szulc; M C Chapuy; P J Meunier; P D Delmas
Journal:  Bone       Date:  1996-05       Impact factor: 4.398

View more
  7 in total

1.  Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women.

Authors:  X-Y Wu; X-P Wu; H Xie; H Zhang; Y-Q Peng; L-Q Yuan; X Su; X-H Luo; E-Y Liao
Journal:  Osteoporos Int       Date:  2009-06-27       Impact factor: 4.507

2.  Association between osteocalcin and glucose metabolism: a meta-analysis.

Authors:  D-M Liu; X-Z Guo; H-J Tong; B Tao; L-H Sun; H-Y Zhao; G Ning; J-M Liu
Journal:  Osteoporos Int       Date:  2015-06-19       Impact factor: 4.507

3.  Brief Report: Undercarboxylated Osteocalcin Is Associated With Cognition in Women With and Without HIV.

Authors:  Ryan D Ross; Arnold Z Olali; Qiuhu Shi; Donald R Hoover; Anjali Sharma; Kathleen M Weber; Audrey L French; Heather McKay; Phyllis C Tien; Michael T Yin; Leah H Rubin
Journal:  J Acquir Immune Defic Syndr       Date:  2022-10-01       Impact factor: 3.771

4.  The serum undercarboxylated osteocalcin level and the diet of a Japanese population: results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  Norihiro Furusyo; Takeshi Ihara; Takeo Hayashi; Hiroaki Ikezaki; Kazuhiro Toyoda; Eiichi Ogawa; Kyoko Okada; Mosaburo Kainuma; Masayuki Murata; Jun Hayashi
Journal:  Endocrine       Date:  2012-09-22       Impact factor: 3.633

5.  Low serum osteocalcin concentration is associated with incident type 2 diabetes mellitus in Japanese women.

Authors:  Tomohiko Urano; Masataka Shiraki; Tatsuhiko Kuroda; Shiro Tanaka; Fumihiko Urano; Kazuhiro Uenishi; Satoshi Inoue
Journal:  J Bone Miner Metab       Date:  2017-08-01       Impact factor: 2.626

6.  Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women.

Authors:  Sacide Atalay; Abdullah Elci; Huseyin Kayadibi; Can B Onder; Nurettin Aka
Journal:  Ann Lab Med       Date:  2011-12-20       Impact factor: 3.464

Review 7.  The Relationship between Follicle-stimulating Hormone and Bone Health: Alternative Explanation for Bone Loss beyond Oestrogen?

Authors:  Kok-Yong Chin
Journal:  Int J Med Sci       Date:  2018-09-07       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.